gefitinib has been researched along with phosphothreonine in 1 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (phosphothreonine) | Trials (phosphothreonine) | Recent Studies (post-2010) (phosphothreonine) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 1,217 | 0 | 249 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hoque, A; Li, J; Liu, Z; Oakhill, J; Proud, CG; Qi, X; Wang, G; Wang, X; Wang, Y; Wu, Y; Xiao, M; Xie, J | 1 |
1 other study(ies) available for gefitinib and phosphothreonine
Article | Year |
---|---|
The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2.
Topics: Animals; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Elongation Factor 2 Kinase; Gefitinib; HEK293 Cells; Humans; Lung Neoplasms; Membrane Proteins; Mice, Nude; Phosphorylation; Phosphothreonine; Protein Multimerization; Proto-Oncogene Proteins c-myc; STAT3 Transcription Factor; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Tumor Burden | 2020 |